REG - Societe Generale SA NEX Group PLC CME Group Inc. - Form 8.3 - CME Group Inc
RNS Number : 1663GSociete Generale SA02 November 2018FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser:
Société Générale S.A.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
Use a separate form for each offeror/offeree
CME Group Inc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:
For an opening position disclosure, state the latest practicable date prior to the disclosure
01/11/2018
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
YES: NEX Group Plc
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security:
Ordinary
Interests
Short positions
Number
%
Number
%
(1) Relevant securities owned and/or controlled:
349,240
0.10
121,226
0.04
(2) Cash-settled derivatives:
34,956
0.01
3,094
0.00
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
0
0.00
0
0.00
TOTAL:
384,196
0.11
124,320
0.04
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security
Purchase/sale
Number of securities
Price per unit
USD
Ordinary
Purchase
830
186.110407
Ordinary
Purchase
33
183.75
Ordinary
Purchase
63
183.520159
Ordinary
Purchase
5,086
183.979915
Ordinary
Purchase
1,793
183.833586
Ordinary
Purchase
1,200
183.817383
Ordinary
Purchase
1,062
183.75
Ordinary
Purchase
640
183.635844
Ordinary
Purchase
14
183.76
Ordinary
Purchase
14
184.29
Ordinary
Purchase
600
183.36
Ordinary
Purchase
1,485
183.75
Ordinary
Purchase
16
183.75
Ordinary
Purchase
200
183.95
Ordinary
Purchase
256,589
183.985366
Ordinary
Purchase
256,589
183.985366
Ordinary
Sale
100
183.76
Ordinary
Sale
7,265
183.708142
Ordinary
Sale
16,477
184.173308
Ordinary
Sale
100
185.98
Ordinary
Sale
610
184.653607
Ordinary
Sale
200
184.055
Ordinary
Sale
3,100
184.292581
Ordinary
Sale
3,466
184.718647
Ordinary
Sale
1,100
183.75
Ordinary
Sale
31
183.6
Ordinary
Sale
9
183.86
Ordinary
Sale
500
185.198
Ordinary
Sale
800
183.80375
Ordinary
Sale
1,100
183.619091
Ordinary
Sale
300
183.68
Ordinary
Sale
1,400
184.720714
Ordinary
Sale
50
184.72
Ordinary
Sale
15,728
183.24
Ordinary
Sale
13,668
183.75
Ordinary
Sale
200
183.95
Ordinary
Sale
256,589
184.195506
Ordinary
Sale
256,589
184.195506
Total Purchases
526,214
Total Sales
579,382
(b) Cash-settled derivative transactions
Class of relevant security
Product description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities
Price per unit USD
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security
Product description e.g. call option
Writing, purchasing, selling, varying etc.
Number of securities to which option relates
Exercise price per unit
Type
e.g. American, European etc.
Expiry date
Option money paid/ received per unit USD
(ii) Exercise
Class of relevant security
Product description
e.g. call option
Exercising/ exercised against
Number of securities
Exercise price per unit USD
(d) Other dealings (including subscribing for new securities)
Class of relevant security
Nature of dealing
e.g. subscription, conversion
Details
Price per unit (if applicable) USD
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached?
NO
Date of disclosure:
02/11/2018
Contact name:
Olivier Vero
Telephone number:
+44 20 7676 6969
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDRETLIFSTLRLFIIT
Recent news on CME
See all newsEU close to addressing too-big-to-fail financial clearing house issue
AnnouncementREG - CME Group Inc. NEX Group Limited - Offer Update
AnnouncementREG-Van Eck Associates Form 8.3 - Barrick Gold Corp.
AnnouncementREG - Omni Partners LLP CME Group Inc. - Form 8.3 - CME Group Inc
AnnouncementREG - BlackRock Group CME Group Inc. - Form 8.3 - CME Group Inc
Announcement